journal article·2020-07-22

Novel Extrusion-Microdrilling Approach to Fabricate Calcium Phosphate-Based Bioceramic Scaffolds Enabling Fast Bone Regeneration

Fupo He, Teliang Lu, Xibo Fang, Songheng Feng, Shenglei Feng, Ye Tian, Yanhui Li, Fei Zuo, Xin Deng, Jiandong Ye

ACS Applied Materials & Interfaces· Volume 12· Issue 29
Publisher page

Abstract

This study proposes a novel approach, termed extrusion-microdrilling, to fabricate three-dimensional (3D) interconnected bioceramic scaffolds with channel-like macropores for bone regeneration. The extrusion-microdrilling method is characterized by ease of use, high efficiency, structural flexibility, and precision. The 3D interconnected β-tricalcium phosphate bioceramic (EM-TCP) scaffolds prepared by this method showed channel-like square macropores (∼650 μm) by extrusion and channel-like round macropores (∼570 μm) by microdrilling as well as copious micropores. By incorporating a strontium-containing phosphate-based glass (SrPG), the obtained calcium phosphate-based bioceramic (EM-TCP/SrPG) scaffolds had noticeably higher compressive strength, lower porosity, and smaller macropore size, tremendously enhanced in vitro proliferation and osteogenic differentiation of mouse bone marrow stromal cells, and suppressed in vitro osteoclastic activities of RAW264.7 cells, as compared with the EM-TCP scaffolds. In vivo assessment results indicated that at postoperative week 6, new vessels and a large percentage of new bone tissues (24-25%) were formed throughout the interconnected macropores of EM-TCP and EM-TCP/SrPG, which were implanted in the femoral defects of rabbits; the bone formation of the EM-TCP group was comparable to that of the EM-TCP/SrPG group. At 12 weeks postimplantation, the bone formation percentage of EM-TCP was slightly reduced, while that of EM-TCP/SrPG with a slower degradation rate was pronouncedly increased. This work provides a new strategy to fabricate interconnected bioceramic scaffolds allowing for fast bone regeneration, and the EM-TCP/SrPG scaffolds are promising for efficiently repairing bone defects.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Electromechanical Engineering, Guangdong University of Technology, Guangzhou 510006, People’s Republic of China

Jihua Laboratory, Foshan 528200, People’s Republic of China

School of Materials Science and Engineering, South China University of Technology, Guangzhou 510641, People’s Republic of China

School of Civil Engineering, Hebei University of Engineering, Handan 056038, People’s Republic of China

Funding

Guangzhou Science, Technology and Innovation Commission · National Natural Science Foundation of China · Heyuan Science and Technology Project · Jihua Laboratory Project

References (68)

Show source-provided references
1. 10.1016/j.biomaterials.2018.07.01710.1016/j.biomaterials.2018.07.017 ↗
2. 10.1016/j.actbio.2017.01.07610.1016/j.actbio.2017.01.076 ↗
3. 10.1016/j.biomaterials.2005.02.00210.1016/j.biomaterials.2005.02.002 ↗
4. 10.1016/j.actbio.2016.04.03910.1016/j.actbio.2016.04.039 ↗
5. 10.1016/S0142-9612(00)00030-210.1016/S0142-9612(00)00030-2 ↗
6. 10.1002/term.2410.1002/term.24 ↗
7. 10.1088/1748-6041/1/2/00210.1088/1748-6041/1/2/002 ↗
8. 10.1038/nmat142110.1038/nmat1421 ↗
9. 10.1016/S0142-9612(97)00180-410.1016/S0142-9612(97)00180-4 ↗
10. 10.1073/pnas.121779611010.1073/pnas.1217796110 ↗
11. 10.1039/C4BM00291A10.1039/C4BM00291A ↗
12. 10.1016/j.actbio.2018.09.00310.1016/j.actbio.2018.09.003 ↗
13. 10.1021/acsami.7b1417510.1021/acsami.7b14175 ↗
14. 10.1016/j.actbio.2012.10.02010.1016/j.actbio.2012.10.020 ↗
15. 10.1039/C4TB01073F10.1039/C4TB01073F ↗
16. 10.1021/am507333q10.1021/am507333q ↗
17. 10.1016/j.biomaterials.2013.09.05610.1016/j.biomaterials.2013.09.056 ↗
18. 10.1016/j.biomaterials.2003.10.06610.1016/j.biomaterials.2003.10.066 ↗
19. 10.1016/j.actbio.2011.08.01910.1016/j.actbio.2011.08.019 ↗
20. 10.1016/j.actbio.2018.11.03910.1016/j.actbio.2018.11.039 ↗
21. 10.1023/B:JMSM.0000004006.90399.b410.1023/B:JMSM.0000004006.90399.b4 ↗
22. 10.1088/1758-5090/aa6a6210.1088/1758-5090/aa6a62 ↗
23. 10.1002/adhm.20150016810.1002/adhm.201500168 ↗
24. 10.1002/jbm.b.3293510.1002/jbm.b.32935 ↗
25. 10.1016/j.ceramint.2017.02.09410.1016/j.ceramint.2017.02.094 ↗
26. 10.1016/j.ceramint.2017.09.06610.1016/j.ceramint.2017.09.066 ↗
27. 10.1111/jace.1551410.1111/jace.15514 ↗
28. 10.1016/j.msec.2017.08.03910.1016/j.msec.2017.08.039 ↗
29. 10.1007/s00170-020-05038-x10.1007/s00170-020-05038-x ↗
30. 10.3390/mi802005310.3390/mi8020053 ↗
31. 10.1016/j.actbio.2012.11.02910.1016/j.actbio.2012.11.029 ↗
32. 10.1016/j.tibtech.2013.06.00510.1016/j.tibtech.2013.06.005 ↗
33. 10.1016/j.pharmthera.2012.07.00910.1016/j.pharmthera.2012.07.009 ↗
34. 10.1021/acsami.6b1037810.1021/acsami.6b10378 ↗
35. 10.1016/j.actbio.2015.01.02210.1016/j.actbio.2015.01.022 ↗
36. 10.1021/acsami.7b0652110.1021/acsami.7b06521 ↗
37. 10.1021/acsami.9b1021910.1021/acsami.9b10219 ↗
38. 10.1002/jbm.a.3081510.1002/jbm.a.30815 ↗
39. 10.1016/j.surfcoat.2006.10.01210.1016/j.surfcoat.2006.10.012 ↗
40. 10.1111/j.1551-2916.2012.05356.x10.1111/j.1551-2916.2012.05356.x ↗
41. 10.1016/S0142-9612(03)00546-510.1016/S0142-9612(03)00546-5 ↗
42. 10.1016/S0142-9612(01)00025-410.1016/S0142-9612(01)00025-4 ↗
43. 10.1016/j.jmbbm.2018.06.03610.1016/j.jmbbm.2018.06.036 ↗
44. 10.1002/jbm.a.3664410.1002/jbm.a.36644 ↗
45. 10.1016/j.colsurfb.2018.04.02810.1016/j.colsurfb.2018.04.028 ↗
46. 10.1016/S0022-3093(01)00912-710.1016/S0022-3093(01)00912-7 ↗
47. 10.1016/j.msec.2015.02.01910.1016/j.msec.2015.02.019 ↗
48. 10.1563/0-742.110.1563/0-742.1 ↗
49. 10.1006/bbrc.2000.410810.1006/bbrc.2000.4108 ↗
50. 10.1016/j.msec.2013.03.00410.1016/j.msec.2013.03.004 ↗
51. 10.1016/j.actbio.2008.07.03510.1016/j.actbio.2008.07.035 ↗
52. 10.1093/ndt/gfs52010.1093/ndt/gfs520 ↗
53. 10.1016/j.msec.2013.02.04410.1016/j.msec.2013.02.044 ↗
54. 10.1007/s10856-015-5523-210.1007/s10856-015-5523-2 ↗
55. 10.1177/088532821666483910.1177/0885328216664839 ↗
56. 10.1021/acsbiomaterials.6b0063210.1021/acsbiomaterials.6b00632 ↗
57. 10.1016/j.actbio.2016.08.02510.1016/j.actbio.2016.08.025 ↗
58. 10.1016/j.biomaterials.2010.01.05210.1016/j.biomaterials.2010.01.052 ↗
59. 10.1007/s10856-005-6988-110.1007/s10856-005-6988-1 ↗
60. 10.2217/rme-2018-002210.2217/rme-2018-0022 ↗
61. 10.1021/acsami.5b0891110.1021/acsami.5b08911 ↗
62. 10.1002/adfm.20160263110.1002/adfm.201602631 ↗
63. 10.1002/adfm.20130290110.1002/adfm.201302901 ↗
64. 10.1021/acsami.6b0772510.1021/acsami.6b07725 ↗
65. 10.1016/j.injury.2011.06.00810.1016/j.injury.2011.06.008 ↗
66. 10.1089/ten.tea.2010.028110.1089/ten.tea.2010.0281 ↗
67. 10.22203/eCM.v028a2110.22203/eCM.v028a21 ↗
68. 10.1002/term.185110.1002/term.1851 ↗